Hypoxia-targeted drug delivery

Amit Sharma, Jonathan F. Arambula, Seyoung Koo, Rajesh Kumar, Hardev Singh, Jonathan L. Sessler, Jong Seung Kim

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Hypoxia is a state of low oxygen tension found in numerous solid tumours. It is typically associated with abnormal vasculature, which results in a reduced supply of oxygen and nutrients, as well as impaired delivery of drugs. The hypoxic nature of tumours often leads to the development of localized heterogeneous environments characterized by variable oxygen concentrations, relatively low pH, and increased levels of reactive oxygen species (ROS). The hypoxic heterogeneity promotes tumour invasiveness, metastasis, angiogenesis, and an increase in multidrug-resistant proteins. These factors decrease the therapeutic efficacy of anticancer drugs and can provide a barrier to advancing drug leads beyond the early stages of preclinical development. This review highlights various hypoxia-targeted and activated design strategies for the formulation of drugs or prodrugs and their mechanism of action for tumour diagnosis and treatment.

Original languageEnglish
Pages (from-to)771-813
Number of pages43
JournalChemical Society Reviews
Volume48
Issue number3
DOIs
Publication statusPublished - 2019 Feb 7

Fingerprint

Tumors
Oxygen
Pharmaceutical Preparations
Neoplasms
Drug Compounding
Prodrugs
Nutrients
Reactive Oxygen Species
Neoplasm Metastasis
Food
Hypoxia
Targeted drug delivery
Proteins
Therapeutics

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Sharma, A., Arambula, J. F., Koo, S., Kumar, R., Singh, H., Sessler, J. L., & Kim, J. S. (2019). Hypoxia-targeted drug delivery. Chemical Society Reviews, 48(3), 771-813. https://doi.org/10.1039/c8cs00304a

Hypoxia-targeted drug delivery. / Sharma, Amit; Arambula, Jonathan F.; Koo, Seyoung; Kumar, Rajesh; Singh, Hardev; Sessler, Jonathan L.; Kim, Jong Seung.

In: Chemical Society Reviews, Vol. 48, No. 3, 07.02.2019, p. 771-813.

Research output: Contribution to journalReview article

Sharma, A, Arambula, JF, Koo, S, Kumar, R, Singh, H, Sessler, JL & Kim, JS 2019, 'Hypoxia-targeted drug delivery', Chemical Society Reviews, vol. 48, no. 3, pp. 771-813. https://doi.org/10.1039/c8cs00304a
Sharma A, Arambula JF, Koo S, Kumar R, Singh H, Sessler JL et al. Hypoxia-targeted drug delivery. Chemical Society Reviews. 2019 Feb 7;48(3):771-813. https://doi.org/10.1039/c8cs00304a
Sharma, Amit ; Arambula, Jonathan F. ; Koo, Seyoung ; Kumar, Rajesh ; Singh, Hardev ; Sessler, Jonathan L. ; Kim, Jong Seung. / Hypoxia-targeted drug delivery. In: Chemical Society Reviews. 2019 ; Vol. 48, No. 3. pp. 771-813.
@article{49f25d1edd0b47fa8b32b9454d80787a,
title = "Hypoxia-targeted drug delivery",
abstract = "Hypoxia is a state of low oxygen tension found in numerous solid tumours. It is typically associated with abnormal vasculature, which results in a reduced supply of oxygen and nutrients, as well as impaired delivery of drugs. The hypoxic nature of tumours often leads to the development of localized heterogeneous environments characterized by variable oxygen concentrations, relatively low pH, and increased levels of reactive oxygen species (ROS). The hypoxic heterogeneity promotes tumour invasiveness, metastasis, angiogenesis, and an increase in multidrug-resistant proteins. These factors decrease the therapeutic efficacy of anticancer drugs and can provide a barrier to advancing drug leads beyond the early stages of preclinical development. This review highlights various hypoxia-targeted and activated design strategies for the formulation of drugs or prodrugs and their mechanism of action for tumour diagnosis and treatment.",
author = "Amit Sharma and Arambula, {Jonathan F.} and Seyoung Koo and Rajesh Kumar and Hardev Singh and Sessler, {Jonathan L.} and Kim, {Jong Seung}",
year = "2019",
month = "2",
day = "7",
doi = "10.1039/c8cs00304a",
language = "English",
volume = "48",
pages = "771--813",
journal = "Chemical Society Reviews",
issn = "0306-0012",
publisher = "Royal Society of Chemistry",
number = "3",

}

TY - JOUR

T1 - Hypoxia-targeted drug delivery

AU - Sharma, Amit

AU - Arambula, Jonathan F.

AU - Koo, Seyoung

AU - Kumar, Rajesh

AU - Singh, Hardev

AU - Sessler, Jonathan L.

AU - Kim, Jong Seung

PY - 2019/2/7

Y1 - 2019/2/7

N2 - Hypoxia is a state of low oxygen tension found in numerous solid tumours. It is typically associated with abnormal vasculature, which results in a reduced supply of oxygen and nutrients, as well as impaired delivery of drugs. The hypoxic nature of tumours often leads to the development of localized heterogeneous environments characterized by variable oxygen concentrations, relatively low pH, and increased levels of reactive oxygen species (ROS). The hypoxic heterogeneity promotes tumour invasiveness, metastasis, angiogenesis, and an increase in multidrug-resistant proteins. These factors decrease the therapeutic efficacy of anticancer drugs and can provide a barrier to advancing drug leads beyond the early stages of preclinical development. This review highlights various hypoxia-targeted and activated design strategies for the formulation of drugs or prodrugs and their mechanism of action for tumour diagnosis and treatment.

AB - Hypoxia is a state of low oxygen tension found in numerous solid tumours. It is typically associated with abnormal vasculature, which results in a reduced supply of oxygen and nutrients, as well as impaired delivery of drugs. The hypoxic nature of tumours often leads to the development of localized heterogeneous environments characterized by variable oxygen concentrations, relatively low pH, and increased levels of reactive oxygen species (ROS). The hypoxic heterogeneity promotes tumour invasiveness, metastasis, angiogenesis, and an increase in multidrug-resistant proteins. These factors decrease the therapeutic efficacy of anticancer drugs and can provide a barrier to advancing drug leads beyond the early stages of preclinical development. This review highlights various hypoxia-targeted and activated design strategies for the formulation of drugs or prodrugs and their mechanism of action for tumour diagnosis and treatment.

UR - http://www.scopus.com/inward/record.url?scp=85060630431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060630431&partnerID=8YFLogxK

U2 - 10.1039/c8cs00304a

DO - 10.1039/c8cs00304a

M3 - Review article

VL - 48

SP - 771

EP - 813

JO - Chemical Society Reviews

JF - Chemical Society Reviews

SN - 0306-0012

IS - 3

ER -